LitAlert ~~ GeneLit.com

    • Pregnancy after breast cancer in BRCA1/2 mutation carriers.
    • Maksimenko J, Irmejs A, Gardovskis J.
    • Hered Cancer Clin Pract. 2022 Jan 21;20(1):3. doi: 10.1186/s13053-022-00209-1.
    • Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
    • Kasuga A, Okamoto T, Udagawa S, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Matsuyama M, Sasaki T, Ozaka M, Ueki A, Sasahira N.
    • Int J Mol Sci. 2022 Jan 21;23(13):1205. doi: 10.3390/ijms23031205.
    • Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography.
    • Sasada S, Masumoto N, Emi A, Kadoya T, Okada M.
    • Sci Rep. 2022 Jan 21;12(1):1144. doi: 10.1038/s41598-022-05166-2.
    • Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
    • Xia YY, Gronwald J, Karlan B, Lubinski J, McCuaig JM, Brooks J, Moller P, Eisen A, Sun S, Senter L, Bordeleau L, Neuhausen SL, Singer CF, Tung N, Foulkes WD, Sun P, Narod SA, Kotsopoulos J; Hereditary Ovarian Cancer Clinical Study Group.
    • Gynecol Oncol. 2022 Jan 18:S0090-8258(22)00022-1. doi: 10.1016/j.ygyno.2022.01.014. Epub ahead of print.